Espa?ol
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Nasal Cavity and Paranasal Sinuses Cancer
Cancers of the nasal cavity and paranasal sinuses are rare, and make up about 3% to 5% of all head and neck cancers in the United States.
Most cancers in the nasal cavity and paranasal sinuses are squamous cell cancers.
About 4 out of 5 cases occur in people who are 55 years old or older.
In the US, White people are much more likely to develop these cancers than Black people, and men are about twice more likely than women to get these cancers. These cancers occur much more often in certain areas of the world such as Denmark.
Most cancers of the nasal cavity and paranasal sinuses occur in the maxillary sinuses or in the nasal cavity. They are less common in the ethmoid sinuses, and are rare in the frontal and sphenoid sinuses.
Survival statistics for these cancers are covered in the section Survival Rates for Nasal Cavity and Paranasal Sinus Cancers, by Stage.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
Bossi P, Farina D, Gatta G, Lombardi D, Nicolai P, Orlandi E. Paranasal sinus cancer. Crit Rev Oncol Hematol. 2016;98:45-61. doi:10.1016/j.critrevonc.2015.09.009.
Dutta R, Dubal PM, Svider PF, Liu JK, Baredes S, Eloy JA. Sinonasal malignancies: A population-based analysis of site-specific incidence and survival. Laryngoscope. 2015;125(11):2491-2497. doi:10.1002/lary.25465.
K?l?? S, K?l?? SS, Kim ES, et al. Significance of human papillomavirus positivity in sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol. 2017;7(10):980-989. doi:10.1002/alr.21996.
National Cancer Institute. Physician Data Query (PDQ). Paranasal Sinus and Nasal Cavity Cancer Treatment. August 22, 2019. Accessed at https://www.cancer.gov/types/head-and-neck/hp/adult/paranasal-sinus-treatment-pdq on November 10, 2020.
Sanghvi S, Khan MN, Patel NR, Yeldandi S, Baredes S, Eloy JA. Epidemiology of sinonasal squamous cell carcinoma: a comprehensive analysis of 4994 patients. Laryngoscope. 2014;124(1):76-83. doi:10.1002/lary.24264.
Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34(6):877-885. doi:10.1002/hed.21830.
Youlden DR, Cramb SM, Peters S, et al. International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiol. 2013;37(6):770-779. doi:10.1016/j.canep.2013.09.014.
Last Revised: April 19, 2021
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.